1LINDSAY M M, MAXWELL P, DUNN F G. TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension[J]. Hypertension, 2002,40(2): 136-141.
2WERBER K T, BRILLA C G, JANICKI J S. Myocardia fibrosis: functional significance and regulatory factors [J].Cardiovasc Res,1993, 27(3): 341-348.
3KHATTAR R S, ACHARYA D U, KINSEY C, et al.Longitudinal association of ambulatory pulse pressure with left ventricular mass and vascular hypertrophy in essential hypertension[J]. J Hypertens, 1997,15(7) :737-743.
4MATRISIAN L M. The matrix-degrading metalloproteinases[J]. Bioessays, 1992,14(7): 455-463.
5GOMEZ D E, ALONSO D F, YOSHIJI H, et al. Tissue inhibitors of metalloproteinases: structure regulation and biological functions[J]. Eur J Cell Biol, 1997, 74(2): 111-122.
8DEVEREUX R B,REICHEK N.Echocardiographic determination of left ventircular mass in man.Anatomic validation of the method[J].Circulation,1977,55(4):613-618.
9TYAGI S C,LEWIS K,PIKES D,et al.Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells[J].J Cell Physiol,1998,176(2):374-382.
10ROTEN L,NEMOTO S,SIMSIC J,et al.Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase type 1(TIMP-1)on left ventricular geometry and function in mice[J].J Mol Cell Cardiol,2000,32(1):109-120.
